Selected Publications

Wong F, Adebayo D, George J, Idilman R, Hayes PC, Alvares-da-Silva MR, Torre A, Mekonnen HD, Seto WK, Sarin SK, Cao Z, Rajoriya N, Nagral A, Fisseha H, Kulkarni AV, Zhu C, Debzi N, Farias AQ, Su M, Goel A, Marciano S, Livingstone R, Dhiman RK, Gao Y, Malé-Velázquez R, Demitars CO, Bera C, Jiang YF, Velarde-Ruiz Velasco JA, Tan HK, Zhao C, Huezo MSG, Asrani SK, Wang L, Lu M, Michalczuk MT, Barutcu S, Cordova-Gallardo J, Gofton C, Gounder M, Shaw J, Albhaisi S, Zheng X, Aravinthan A, Rajaram RB, Jothimani D, Thanapirom K, Benitez C, Dincer D, Saraya A, Xu B, Lin M, Wu X, Liu C, Reddy KR, et al.: Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective. Gut June 2026.

Bajaj JS, Reddy KR, Tandon P, Lai JC, O'Leary JG, Wong F, et al. : Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort. Hepatology 83(6): 1483-1494, June 2026.

Premkumar M, Kajal K, Roy A, Izzy M, Divyaveer S, Kulkarni AV, Artru F, Sharma P, Sandhu A, Sihag BK, Bahl A, De A, Verma N, Taneja S, Duseja AK, Pal A, Bhujade H, Reddy KR. : Point-of-care ultrasound (POCUS)-guided volume management and the effect of cirrhotic cardiomyopathy on acute kidney injury outcomes in cirrhosis. Hepatology 83(6): 1495-1514, June 2026.

Lai J, O'Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Biggins SW, Vargas HE, Thacker LR, Bush BJ, Silvey S, Reddy KR, et al. : Frailty Increases Hospitalization Rates in an Ambulatory Cohort of Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease 3 Prospective Cohort. Clin Gastroenterol Hepatol May 2026.

Malicote D, Im G, Weinberg E, Kwong A, Shasthry SM, Rastogi A, Tondon R, Verma N, Valsan A, Kwo P, Reddy KR, et al. : Ahead, a Novel Validated Machine Learning Model for Clinical Diagnosis of Alcohol Associated Hepatitis. Res Sq May 2026.

Kulkarni AV, Venishetty S, Prasanna S, Iyengar S, Sarada SV, Premkumar M, Sharma M, Alla M, Rao PN, Reddy DN, Reddy KR: Midodrine versus placebo in patients with acute-on-chronic liver failure with ascites-A randomized trial (MIDAS trial). Hepatol Commun. 10(6), May 2026.

10. Silvey S, Choudhury AK, Kamath PS, Xie Q, Wong F, Hayes PC, Seto WK, Arora U, Singhal G, Jothimani D, Asrani S, Gadano A, Dincer D, Farias AQ, Adebayo D, Velarde-Ruiz Velasco JA, Doyle A, Kulkarni AV, Debzi N, Shaw J, Barutcu S, Desalgn H, Bettinger D, Regis Lah PC, Duarte-Rojo A, Turan D, Wang L, Velazquez RM, Zheng X, Aghayaeva S, Karasu Z, Demirtas C, Liu C, Cordova-Gallardo J, Xu B, Nagral A, Gao H, Elangovan H, Fung J, Rajorya N, Wang X, Katchmann H, Praharaj D, Mahadeva S, Jiang Y, Zheng K, Thanapirom K, Eapen CE, Dhiman RK, Lu M, Arrese M, Su M, Hueso SG, Zhu C, Aberra H, Fisseha H, Tan HK, Zhao C, Zhang N, Taneja S, Aravinthan AD, Sonavane A, Saraya A, Gofton C, MacQuillan G, Pereira G, Reddy KR, et al. : Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort. Am J Gastroenterol April 2026.

Roy A, Jajodia S, Chakraborty S, Keyal S, Tewari A, Sonthalia N, Roy S, Khandelwal R, Kulkarni A, Ghoshal UC, Reddy KR, et al. : Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis. BMC Gastroenterol. 26(1): 329, April 2026.

McCullough AA, Mahmud N, Reddy KR, Bittermann T. : Delisting for clinical improvement as a proxy for recompensated cirrhosis on the U.S. liver transplant waitlist: A retrospective cohort study. Liver Transpl. April 2026.

9. Sánchez-Torrijos Y, Torres-Domínguez A, Carmona I, Ibáñez-Samaniego L, Román E, Casado M, García-Cortés M, Jimeno C, Rosales-Zabal JM, Fernández-Álvarez P, Sendra C, López-Garrido Á, Ballester MP, Rodríguez-Perálvarez M, Estévez M, García-García A, Jiménez-Pérez M, Del Pino P, Santamaría G, Sánchez J, Zamora J, Rodríguez M, Castillo L, Aguilera V, Romero G, Reddy KR, et al. : REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated Cirrhosis. Liver Int. 46(5), April 2026.